Atlas Trials

Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

Clinical trial NCT04736108 · UNKNOWN

Trial details

NCT number
NCT04736108
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2021-05-01
Primary completion
2022-10-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.